(Q54174598)

English

In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levels

scientific article published on May 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levels (English)

reason for preferred rank

most precise value

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587048

26 May 2024

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C. W. Stratton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587048

26 May 2024

K. E. Aldridge

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587048

26 May 2024

M. S. Gelfand

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587048

26 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7587048

26 May 2024

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

full work available at URL

https://api.elsevier.com/content/article/PII:073288939500094Q?httpAccept=text/xml

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

https://api.elsevier.com/content/article/PII:073288939500094Q?httpAccept=text/plain

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

22

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

1-2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

35-42

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

World-wide development of antibiotic resistance in pneumococci

1

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Cefotaxime diffusion into cerebrospinal fluid of children with meningitis

2

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Emergence of drug-resistant pneumococcal infections in the United States

3

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

4

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis

5

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

6

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

7

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.

8

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.

9

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.

10

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

11

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy

12

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae

15

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Evaluation of the E-Test for susceptibility testing of pneumococci

16

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics

19

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae

20

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture

21

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.

22

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review

24

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin

25

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges

28

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Emerging role of cephalosporins in bacterial meningitis

29

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

The new beta-lactamase-stable cephalosporins

30

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Treatment of bacterial meningitis with ceftizoxime

31

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b

32

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Antibiotic therapy of bacterial meningitis: lessons we've learned

33

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

34

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins

35

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Antibacterial Activity of -Lactam Antibiotics in Experimental Meningitis Due to Streptococcus pneumoniae

36

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults.

37

1 reference

10.1016/0732-8893(95)00094-Q

https://api.crossref.org/works/10.1016/0732-8893(95)00094-Q

26 May 2024

Identifiers

10.1016/0732-8893(95)00094-Q

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/7587048

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54174598&oldid=2164936319"